Fasani et al.
for a number of applications,16 (ii) a better knowledge of the
relatively little explored photochemistry of 3-nitrobenzyl deriva-
tives15 would be obtained, and (iii) a rationale for the photo-
lability (and possibly the phototoxicity) of such drugs may be
offered.
SCHEME 1
Results
Photoreactions. The compounds considered in this study
were esters of the 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-
pyridine-3,5-dicarboxylic acid. These were the dimethyl ester
1, distinguished from nifedipine only by the position of the nitro
group, the corresponding methyl ethyl ester 2, the drug
nitrendipine, as well as two derivatives containing a functional
group in one of the ester alkyl chains, namely the isopropyl
methoxyethyl ester 3 (nimodipine) and the methyl N-(methyl)-
N-(benzyl)aminoethyl ester 4 (nicardipine). These compounds
exhibit an absorption band in the near UV, with a maximum at
ca. 350 nm (the tail extending in the visible results in a yellow
color) and at ca. 230 nm. They are readily soluble in most
organic solvents, but not in water, and most of the experiments
were carried out in methanol and in acetonitrile, two solvents
of differing hydrogen-donating ability. Irradiations were carried
out at two wavelengths, 254 and 366 nm, corresponding to the
two main band systems and under two conditions, air-
equilibrated and argon-flushed solutions.
Irradiation of the dimethyl ester 1 under all of the above
conditions gave a single product, as determined by HPLC
monitoring. This was identified as the corresponding nitrophen-
ylpyridine 5 by comparison with an authentic sample (Table 1,
Scheme 2). At 50% conversion of 1, product 5 was in every
case ca. 70% of the consumed dihydropyridine. Likewise, both
the methyl ethyl ester 2 and the methyl methoxyethyl ester 3
gave the nitro derivatives 6 and, respectively, 7. With 3, HPLC/
MS analysis showed a minor peak by irradiation at 254 nm in
Ar-flushed MeCN or MeOH, but not under different conditions,
with MW corresponding to the nitroso analogue of compound
7 (8), which was not further investigated in view of the small
amount.
such as ischemia, arteriosclerosis, and stroke for their antioxidant
activity.7c-f Most of these drugs bear a nitro group on the phenyl
ring and thus contain both an easily oxidized and an easily
reduced moiety in the same molecule, a fact that may have a
bearing on their biological activity.8a,b
The donor-acceptor structure8c raises the question of whether
an intramolecular redox reaction may occur, a step that may be
easier under photochemical conditions. Actually, some drugs
of this family are known to be photolabile and must be protected
from light-exposure. The 2-nitrophenyl derivative nifedipine has
been in use for a long time as a coronary vasodilator and is
strongly photoreactive. This has motivated a series of photo-
chemical and photobiologic studies showing that this compound
is converted into the corresponding 2-nitrosophenylpyridine
(Scheme 1),9 a reaction that can be classed among the well-
known intramolecular redox process of 2-nitrobenzyl deriva-
tives,10 and occurs both in solution and in the solid state.
Whether a significant photodecomposition takes place in the
skin after intake of the drug and a toxic effect results is a debated
subject.11
2-Nitrophenyl derivatives are ill suited for the study of
photoinduced electron-transfer processes because of the fast
chemical reaction occurring. Better models can be found among
the “second generation”12 cardiac drugs, some of which contains
the 3-nitrophenyl, rather than the 2-nitrophenyl, moiety. These
have been found to be again photolabile, though at a lower
degree,13 but the available literature is mainly limited to the
determination of the degradation kinetics in drug preparations.14
It appeared to us that a more extensive study of the photochem-
istry of these molecules was warranted because (i) excitation
may induce intramolecular electron transfer between two
moieties held in a definite position, a topic actively investigated
In the case of the aminoethyl ester 4 the results were different,
in that the corresponding nitrophenyl derivative (9, ca. 40% in
MeCN and 20% in MeOH, both argon and air equilibrated) was
accompanied by two further peaks. Separation by column
chromatography after irradiation in acetonitrile allowed recog-
nizing these as nitrophenyldihydropyridines in which the ester
side was modified. Two products were obtained from chroma-
tography, namely the N-benzyl and the N-benzyl-N-formyl
derivatives (10 and 11, respectively, Scheme 3).
(8) (a) Schleifer, K. J. J. Med. Chem. 1999, 42, 2204. (b) Schleifer, K.
J. Pharmazie 1999, 54, 804. (c) Compare Nelsen, S. F. In Electron Transfer
in Chemistry; Balzani, V., Ed.; Wiley-VCH: Weinheim, 2001; Vol. 1, p
342.
(9) (a) Berson, J. A.; Brown, E. J. Am. Chem. Soc. 1955, 77, 447. (b)
Thoma, K.; Kerker, R. Pharm. Ind. 1992, 54, 465. (c) Shim, S. C.; Pae, A.
N.; Lee, Y. J. Bull. Korean Chem. Soc. 1988, 9, 271. (d) Pietta, P.; Rava,
A.; Biondi, P. J. Chromatog. 1981, 210, 516. (d) Stasko, A.; Brazova, V.;
Biskupic, S.; Ondrias, K.; Misik, V. Free Rad. Biol. Med. 1994, 17, 545.
(e) de Vries, H.; Beijersbergen van Henegouwen, G. M. J. Photochem.
Photobiol. B: Biol. 1998, 43, 217. (f) Buttafava, A.; Faucitano, A.; Fasani,
E.; Albini, A. Res. Chem. Intermed. 2002, 28, 231. (g) Fasani, E.; Dondi,
D.; Ricci, A.; Albini, A. Photochem. Photobiol. 2006, 82, in press.
(10) Barltrop, J. A.; Plant, P. J. J. Chem. Soc., Chem. Commun. 1966,
827. Nurmukhametov, R. N.; Sergeev, A. M. Zh. Fiz. Khim. 1990, 64, 308.
Walker, J. W.; Reid, G. P.; McCray, J. A.; Trentham, D. R. J. Am. Chem.
Soc. 1988, 110, 7170.
(11) Al-Ajimi, H. S.; Dawe, R. S.; Renwick, A. G.; Macklin, B. S.;
Ferguson, J.; Gibbs, N. K. Photoderm. Photoim. Photomed. 2000, 16, 111.
Fujii, H.; Berliner, L. J. Magn. Reson. Med. 1999, 42, 691.
(12) Freedman, D. D.; Waters, D. D. Drugs 1987, 34, 578.
(13) Mei, Q.; Shang, P.; Zhao, D.; Zhou, G. Zhongguo Yaoxue Zazhi
1998, 33, 291.
(15) See, e.g.: Muralidharan, S.; Beveridge, K. A.; Wan, P. J. Chem.
Soc., Chem. Commun. 1989, 1426.
(16) Wegenwijs, B.; Verhoeven, J. W. AdV. Chem. Phys. 1999, 106, 221.
Timberlake, L. D.; Morrison, H. J. Am. Chem. Soc. 1999, 121, 3618. Liu,
G.; Heisler, L.; Li, L.; Steinmetz, M. G. J. Am. Chem. Soc. 1996, 118,
11412. Osuka, A.; Noya, G.; Taniguchi, S.; Okada, T.; Nishimura, Y.;
Yamazaki, I.; Mataga, N. Chem. Eur. J. 2000, 6, 33. Maruyama, K.; Osuka,
A.; Mataga, N. Pure Appl. Chem. 1994, 66, 867. Kaplan, R. W.; Napper,
A. M.; Waldeck, D. H.; Zimmt, M. B. J. Am. Chem. Soc. 2000, 122, 12039.
Zhang, L. P.; Chen, B.; Wu, L. Z.; Tung, C. H.; Cao, H.; Tanimoto, Y.
Chem. Eur. J. 2003, 9, 2763. Guo, X.; Zhang, D.; Zhang, H.; Fan, Q.; Xu,
W.; Ai, X.; Fan, L.; Zhu, D. Tetrahedron Lett. 2003, 59, 4843. Miranda,
M. A.; Lahoz, A.; Bosca, F.; Metni, M. R.; Abdelouahab, F. B.; Castell, J.
V.; Perez-Prieto, J. Chem. Commun. 2000, 2257. Le, T. P.; Rogers, J. E.;
Kelly, L. A. J. Phys. Chem A 2000, 104, 6778. Levy, S. T.; Rubin, M. B.;
Speiser, S. J. Am. Chem. Soc. 1992, 114, 10747. Pincock, J. A.; Rifai, S.;
Stefanova, R. Can. J. Chem. 2001, 79, 63. Wagner, P. J.; El-Taliawi, G.
M. J. Am. Chem. Soc. 1992, 117, 8325.
(14) Mielcarek, J. Acta Pol. Pharm. 1995, 52, 59. Mielcarek, J. Acta
Pol. Pharm. 1995, 52, 465. Jakobsen, P.; Mikkelsen, E.; Laursen, J.; Jensen,
F. J. Chromatograph. 1986, 374, 383. Mielcarek, J. Pharmazie 1996, 51,
477.
2038 J. Org. Chem., Vol. 71, No. 5, 2006